BioCardia, Inc. Common Stock BCDA
$0.96
-2.87%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $25.00
- Implied Upside
- +2497.1%
- Price Target Range
- $25.00 – $25.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-09 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $25 |
| 2025-09-22 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $25 |
| 2024-12-18 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $25 |
| 2024-11-14 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $25 |
| 2024-10-28 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $25 |
| 2024-08-21 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $25 |
| 2024-08-16 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $4 → $25 |
| 2024-07-26 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $4 |
| 2024-05-29 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $60 |
| 2023-11-14 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $60 |
| 2023-10-11 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $60 |
| 2023-09-06 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $135 → $60 |
| 2023-08-10 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $135 |
| 2023-07-24 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $135 |
| 2023-06-21 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $135 |
| 2023-05-11 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $135 |
| 2023-03-30 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $135 |
| 2022-11-11 | Dawson JamesJason Kolbert |
Downgrades | Buy → Neutral | — |
| 2021-12-20 | HC Wainwright & Co.Joseph Pantginis |
Initiates coverage on | Buy | $135 |
| 2021-04-16 | Dawson JamesJason Kolbert |
Downgrades | Buy → Neutral | — |
| 2020-09-21 | Alliance Global Partners |
Initiates coverage on | Buy | $173 |
| 2019-11-26 | Brookline Capital |
Initiates coverage on | Buy | $330 |
| 2019-10-10 | Maxim Group |
Initiates coverage on | Buy | $135 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.96
- Market Cap
- $15.00 million
- 52-Week Range
- $0.75 – $2.42
- Average Volume
- 280K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.